EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2226176, encodeId=36bc22261e65a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乙肝 经验分享：四个月录用，一个审稿人，小修半个月录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d49c8319099, createdName=ms1000000602711228, createdTime=Tue Sep 17 09:23:41 CST 2024, time=2024-09-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2210053, encodeId=88fa221005390, content=想问一下有没有今年投稿已经接收的大佬呀？投稿后进入审稿阶段要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2d89300873, createdName=勋勋不懂, createdTime=Sat Jun 15 19:32:23 CST 2024, time=2024-06-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=)]

2020-05-15 xxk7235

这个投稿后如果没有所有作者都确认，是不是就无法送审？

220 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2226176, encodeId=36bc22261e65a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乙肝 经验分享：四个月录用，一个审稿人，小修半个月录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d49c8319099, createdName=ms1000000602711228, createdTime=Tue Sep 17 09:23:41 CST 2024, time=2024-09-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2210053, encodeId=88fa221005390, content=想问一下有没有今年投稿已经接收的大佬呀？投稿后进入审稿阶段要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2d89300873, createdName=勋勋不懂, createdTime=Sat Jun 15 19:32:23 CST 2024, time=2024-06-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=)]

2023-09-22 ms6000001416279458 来自湖北省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肝病方向
经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审

177 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2226176, encodeId=36bc22261e65a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乙肝 经验分享：四个月录用，一个审稿人，小修半个月录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d49c8319099, createdName=ms1000000602711228, createdTime=Tue Sep 17 09:23:41 CST 2024, time=2024-09-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2210053, encodeId=88fa221005390, content=想问一下有没有今年投稿已经接收的大佬呀？投稿后进入审稿阶段要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2d89300873, createdName=勋勋不懂, createdTime=Sat Jun 15 19:32:23 CST 2024, time=2024-06-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=)]

2024-09-17 ms1000000602711228 来自福建省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：乙肝
经验分享：四个月录用，一个审稿人，小修半个月录用

34 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2226176, encodeId=36bc22261e65a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乙肝 经验分享：四个月录用，一个审稿人，小修半个月录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d49c8319099, createdName=ms1000000602711228, createdTime=Tue Sep 17 09:23:41 CST 2024, time=2024-09-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2210053, encodeId=88fa221005390, content=想问一下有没有今年投稿已经接收的大佬呀？投稿后进入审稿阶段要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2d89300873, createdName=勋勋不懂, createdTime=Sat Jun 15 19:32:23 CST 2024, time=2024-06-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=)]

2024-06-15 勋勋不懂来自海南省

想问一下有没有今年投稿已经接收的大佬呀？投稿后进入审稿阶段要多久呀？

93 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2226176, encodeId=36bc22261e65a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乙肝 经验分享：四个月录用，一个审稿人，小修半个月录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d49c8319099, createdName=ms1000000602711228, createdTime=Tue Sep 17 09:23:41 CST 2024, time=2024-09-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2210053, encodeId=88fa221005390, content=想问一下有没有今年投稿已经接收的大佬呀？投稿后进入审稿阶段要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2d89300873, createdName=勋勋不懂, createdTime=Sat Jun 15 19:32:23 CST 2024, time=2024-06-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=)]

2023-08-15 ms1000001347062777 来自北京

请问submit后多久分配稿号？已经7天了，还是submitted to journal

155 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2226176, encodeId=36bc22261e65a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乙肝 经验分享：四个月录用，一个审稿人，小修半个月录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d49c8319099, createdName=ms1000000602711228, createdTime=Tue Sep 17 09:23:41 CST 2024, time=2024-09-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2210053, encodeId=88fa221005390, content=想问一下有没有今年投稿已经接收的大佬呀？投稿后进入审稿阶段要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2d89300873, createdName=勋勋不懂, createdTime=Sat Jun 15 19:32:23 CST 2024, time=2024-06-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=)]

2023-08-08 ms4000001065776869 来自北京

想问问大家现在under review大概多久会给消息？

139 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2226176, encodeId=36bc22261e65a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乙肝 经验分享：四个月录用，一个审稿人，小修半个月录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d49c8319099, createdName=ms1000000602711228, createdTime=Tue Sep 17 09:23:41 CST 2024, time=2024-09-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2210053, encodeId=88fa221005390, content=想问一下有没有今年投稿已经接收的大佬呀？投稿后进入审稿阶段要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2d89300873, createdName=勋勋不懂, createdTime=Sat Jun 15 19:32:23 CST 2024, time=2024-06-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=)]

2023-03-31 1473ac4am82暂无昵称来自四川省

作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。

149 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2226176, encodeId=36bc22261e65a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乙肝 经验分享：四个月录用，一个审稿人，小修半个月录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d49c8319099, createdName=ms1000000602711228, createdTime=Tue Sep 17 09:23:41 CST 2024, time=2024-09-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2210053, encodeId=88fa221005390, content=想问一下有没有今年投稿已经接收的大佬呀？投稿后进入审稿阶段要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2d89300873, createdName=勋勋不懂, createdTime=Sat Jun 15 19:32:23 CST 2024, time=2024-06-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=)]

2018-12-09 fzdndx

审稿速度:1.0 | 投稿命中率:50.0
经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。

360 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2226176, encodeId=36bc22261e65a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乙肝 经验分享：四个月录用，一个审稿人，小修半个月录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d49c8319099, createdName=ms1000000602711228, createdTime=Tue Sep 17 09:23:41 CST 2024, time=2024-09-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2210053, encodeId=88fa221005390, content=想问一下有没有今年投稿已经接收的大佬呀？投稿后进入审稿阶段要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2d89300873, createdName=勋勋不懂, createdTime=Sat Jun 15 19:32:23 CST 2024, time=2024-06-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=)]

2022-07-30 099092753

偏重的研究方向：肝病方向
经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章

163 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2226176, encodeId=36bc22261e65a, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乙肝 经验分享：四个月录用，一个审稿人，小修半个月录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d49c8319099, createdName=ms1000000602711228, createdTime=Tue Sep 17 09:23:41 CST 2024, time=2024-09-17, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2210053, encodeId=88fa221005390, content=想问一下有没有今年投稿已经接收的大佬呀？投稿后进入审稿阶段要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2d89300873, createdName=勋勋不懂, createdTime=Sat Jun 15 19:32:23 CST 2024, time=2024-06-15, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=)]

2019-12-06 147a1e7dm81(暂无昵称)

您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表:
original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。

leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。

276 2 举报

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务